Objective response rate of 54.8% seen with Daiichi Sankyo and Merck’s ifinatamab deruxtecan at 12 mg/kg dose in pretreated patients
The BPaLM regimen, which consists four-drug combination – Bedaquiline, Pretomanid, Linezolid and Moxifloxacin, has been proven to be safe, more effective and a quicker treatment option than the previous MDR-TB treatment procedure
Coal India has committed to providing upto Rs. 3 crore to treat thalassaemia and aplastic anaemia patients for a period of 3 years
Multi-year collaboration focuses on development of biodegradable antimicrobial peptides with broad application possibilities in the areas of skin care and healthcare
The conference aims to bring various stakeholders and experts in the field of healthcare and digital solutions for ensuring ‘universal access to affordable and quality healthcare’
Transform healthcare by integrating expertise from AI, clinical sciences, and basic sciences to harness India’s extensive data sets for improving the access to healthcare
TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industry
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
Innovative product offerings to capitalise on emerging opportunities within and beyond the sexual wellness market
Subscribe To Our Newsletter & Stay Updated
